TWS is developing a topical, advanced wound care dressing. Across the United States, 6.5M people suffer from chronic wounds. 3,000 “me-too” products get pushed into the market, yet fail to effectively treat wounds. This $25B problem is getting worse with rapid growth in costs, obesity, diabetes, and an aging population. We are here to solve this problem. Our Trojan Horse technology initiates the self-destruction of bacteria at personalized doses.